acute high altitude illness
Article Sidebar
Main Article Content
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Sambhara D, Aref AA. Glaucoma management: relative value and place in therapy of available drug treatments. TherAdv Chronic Dis 2014; 5: 30–43. doi: 10.1177/2040622313511286
https://www.medicines.org.uk/emc/medicine/22217
Cleland JC, Griggs RC. Treatment of neuromuscular channelopathies: current concepts and future prospects. Neurotherapeutics 2008; 5: 607-12. doi: 10.1016/j. nurt.2008.09.001.
Smith SV, Friedman DI. The idiopathic intracranial hypertension treatment trial: A review of the outcomes. Headache 2017; 57: 1303-10. doi: 10.1111/head.13144. Epub 2017 Jul 30.
Swenson ER. Carbonic anhydrase inhibitors and high altitude illnesses.SubcellBiochem 2014; 75: 361-86.
Leaf DE, Goldfarb DS. Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness. J ApplPhysiol 2007; 102: 1313-22.
Imray C, Wright A, Subudhi A, Roach R. Acute mountain sickness: pathophysiology, prevention, and treatment. ProgCardiovasc Dis 2010; 52: 467-84
Barsch P, Swenson ER. Acute high altitude illness. N Engl J Med 2013; 368: 2294-302.
Arroll B, Wallace HB, Mount V, Humm SP, Kingsford DW.MedA systematic review and meta-analysis of treatments for acrophobia. J Aust 2017; 206: 263-7.
Eide RP 3rd, Asplund CA. Altitude illness: update on prevention and treatment. Curr Sports Med Rep 2012; 11: 124-30.
Luks AM, McIntosh SE, Grissom CK, Auerbach PS, Rodway GW, Schoene RB, et al. Wilderness Medical Society consensus guidelines for the prevention and treatment of acute altitude illness. Wilderness Environ Med 2010; 21: 146-55.
Saito H, Ogasawara K, Suzuki T, Kuroda H, Kobayashi M, Yoshida K, et al. Adverse effects of intravenous acetazolamide administration for evaluation of cerebrovascular reactivity using brain perfusion single-photon emission computed tomography in patients with major cerebral artery steno-occlusive diseases. Neurol Med Chir (Tokyo) 2011; 51: 479-83.
Moraga FA, Flores A, Serra J, Esnaola C, Barriento C. Ginkgo biloba decreases acute mountain sickness in people ascending to high altitude at Ollagüe (3696 m) in northern Chile. Wilderness Environ Med 2007; 18: 251-7.
Biondich AS, Joslin JD. Coca: The history and medical significance of an ancient Andean Tradition. Emerg Med Int 2016; 2016: 4048764. doi: 10.1155/2016/4048764
https://www.whereverwriter.com/prevent-altitude-sickness-cusco-machu-picchu/